Accession Number: | 0001104659-21-081556 |
Date: | 2021-06-14 |
Issuer: | Y-MABS THERAPEUTICS, INC. (YMAB) |
Original Submission Date: |
GAD THOMAS
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE, SUITE 3350
NEW YORK, NY 10169
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-14 | S | 4,000 | d | $35.80 | 1,599,927 | indirect | f3 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | represents shares sold pursuant to a rule 10b5-1 trading plan adopted on march 25, 2021. |
f2 | this transaction was executed in multiple trades at prices ranging from $35.24 to $36.28. the price reported reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f3 | reporting person is sole member of gad enterprises, llc and the sole member and manager of gad management, llc, the manager of gad enterprises, llc, and as such reporting person has sole voting and dispositive power with respect to such shares. |